OUR PRODUCTS

MOBILE APPS

GENERAL INFO

XNCR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Xencor (XNCR) Earnings Date & Reports

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XNCR is expected to report earnings to rise 82.44% to -74 cents per share on November 10

Q3'25

Est.

$-0.75

Q2'25

Beat

by $0.31

Q1'25

Missed

by $0.04

Q4'24

Beat

by $0.19

Q3'24

Beat

by $0.27

The last earnings report on August 06 showed earnings per share of -40 cents, beating the estimate of -72 cents. With 408.43K shares outstanding, the current market capitalization sits at 552.75M.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

XNCR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For XNCR
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XNCR showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapeutics to treat autoimmune and allergic diseases, cancer and other conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

465 North Halstead Street

Phone

+1 626 305-5900

Employees

256

Web

https://www.xencor.com